Melanocortin receptor agonist (MC1R/MC4R) studied for stimulating melanocyte activity (skin pigmentation/tanning response) and, via MC4R, for effects on libido and appetite; not FDA-approved, associated with documented adverse effects (nausea, flushing, blood pressure changes, and darkening or changes in existing moles that can complicate skin-cancer screening).
Melanocortin receptor agonist (MC1R/MC4R) studied for stimulating melanocyte activity (skin pigmentation/tanning response) and, via MC4R, for effects on libido and appetite; not FDA-approved, associated with documented adverse effects (nausea, flushing, blood pressure changes, and darkening or changes in existing moles that can complicate skin-cancer screening).
| Concentration | 2 mg/mL |
|---|---|
| Volume | 5 mL |
| Total mg/Vial | 10 mg |
